SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037618
Filing Date
2022-11-14
Accepted
2022-11-14 16:01:59
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-10q_20220930.htm   iXBRL 10-Q 2321067
2 EX-31.1 isco-ex311_8.htm EX-31.1 9369
3 EX-31.2 isco-ex312_9.htm EX-31.2 9289
4 EX-32.1 isco-ex321_6.htm EX-32.1 6055
5 EX-32.2 isco-ex322_7.htm EX-32.2 6552
  Complete submission text file 0001564590-22-037618.txt   9635450

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA isco-20220930.xsd EX-101.SCH 57858
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isco-20220930_cal.xml EX-101.CAL 47141
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isco-20220930_def.xml EX-101.DEF 167129
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE isco-20220930_lab.xml EX-101.LAB 385431
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isco-20220930_pre.xml EX-101.PRE 297972
63 EXTRACTED XBRL INSTANCE DOCUMENT isco-10q_20220930_htm.xml XML 2352198
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 221384886
SIC: 2834 Pharmaceutical Preparations